← Open Payments lookup

TIFFANEY COLEMAN: Open Payments

NPI 1770096232 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,530 in 90 payments from 11 companies in 2025. Trend: 2023 $645 · 2024 $796 · 2025 $1,530

Food & beverage: $1,530
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$319
Axsome Therapeutics, Inc.13$286
Neurocrine BioSciences, Inc.12$197
Teva Pharmaceuticals USA, Inc.8$190
E.R. Squibb & Sons, L.L.C.13$159
Alkermes, Inc.9$135
Vanda Pharmaceuticals Inc.4$86
Otsuka America Pharmaceutical, Inc.4$77
ABBVIE INC.2$33
Lundbeck LLC2$30

Products named: CAPLYTA, Auvelity, INGREZZA, UZEDY, COBENFY, ARISTADA, REXULTI, FANAPT.

Industry payments across TX — which companies pay providers there.